South Africa is facing an outbreak of mpox, formerly known as monkeypox, with 20 confirmed cases reported between May 8 and July 2, resulting in three deaths, according to the World Health Organization (WHO).

This development marks the first instances of mpox in the country since 2022, sparking concerns among health officials and the general public.

The cases, all male and ranging in age from 17 to 43, have been identified in three provinces: Gauteng (10 cases), KwaZulu-Natal (nine cases), and the Western Cape (one case).

The majority of those affected have been hospitalized, with several still receiving treatment.

The NICD has revealed that the specific strain of the monkeypox virus causing the outbreak in South Africa is clade 2b, the same variant responsible for outbreaks in Western Europe and the United Kingdom.

The initial case was reported on May 8, prompting the health department to issue a call for public vigilance. Since then, the number of cases has steadily risen, with four more laboratory-confirmed cases announced on July 4, bringing the total to 20.

In response to the growing outbreak, the South African health department has initiated contact tracing and is working to secure vaccines from WHO member countries with stockpiles. The first batch of TPOXX treatment, an antiviral drug effective against mpox, has arrived in the country, with an additional batch expected in the coming weeks.

Health experts stress that mpox is a treatable disease if diagnosed early, emphasizing the importance of seeking medical attention immediately if symptoms arise. The public is urged to remain vigilant and cooperate with health workers during contact tracing and screening.

As the situation continues to unfold, South Africa's health department remains committed to containing the outbreak and ensuring the safety of its citizens. With the number of cases expected to rise in the coming weeks, intensified efforts are underway to combat the spread of mpox.